Indivior PLC (LON:INDV – Get Free Report)’s share price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 888.47 ($11.86) and traded as low as GBX 676.23 ($9.03). Indivior shares last traded at GBX 680 ($9.08), with a volume of 363,132 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,500 ($20.02) price target on shares of Indivior in a research note on Thursday, September 5th.
View Our Latest Analysis on INDV
Indivior Price Performance
Insider Activity at Indivior
In other Indivior news, insider Jo Le Couilliard bought 1,490 shares of the firm’s stock in a transaction dated Friday, July 26th. The stock was acquired at an average price of GBX 1,006 ($13.43) per share, for a total transaction of £14,989.40 ($20,007.21). 3.39% of the stock is owned by insiders.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- What does consumer price index measure?
- The Average 401k Balance by Age Explained
- How is Compound Interest Calculated?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.